Liraglutide (204656-20-2)
Resumen del producto
Liraglutida (204656-20-2) es un agonista del receptor GLP-1 para la diabetes tipo 2 y el control del peso. Presenta secreción de insulina dependiente de glucosa, control del apetito y protección cardiovascular. Polvo blanco almacenado a -20°C. Para uso en I+D.
Atributos personalizados del producto
Descripción del Producto
Liraglutide is an artificially synthesized glucagon-like peptide-1 (GLP-1) receptor agonist, mainly used for the treatment of type 2 diabetes and long-term weight management.
Mechanism of action:
- Blood sugar regulation: Stimulates insulin secretion in a glucose concentration-dependent manner, while reducing glucagon secretion, thereby lowering blood sugar levels.
- Weight control: By delaying gastric emptying and acting on specific areas of the brain to control appetite and food intake, it increases satiety.
- Cardiovascular protection: Has multiple protective effects on the cardiovascular system, including lowering systolic blood pressure.
*The product under patent is only for R&D use.
¡Contacta a nuestros expertos y obtén una consulta gratuita!
Nuestra misión es ofrecer "Alta Calidad", "Buen Servicio" y "Entrega Rápida" para ayudar a nuestros clientes a obtener mayores beneficios.
